Shkreta Lulzim, Toutant Johanne, Durand Mathieu, Manley James L, Chabot Benoit
Département de Microbiologie et d'Infectiologie, Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke, Sherbrooke, QC J1E 4K8, Canada.
Laboratory of Functional Genomics, Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke, Sherbrooke, QC J1E 4K8, Canada.
Cell Rep. 2016 Nov 15;17(8):1990-2003. doi: 10.1016/j.celrep.2016.10.071.
RNA binding proteins and signaling components control the production of pro-death and pro-survival splice variants of Bcl-x. DNA damage promoted by oxaliplatin increases the level of pro-apoptotic Bcl-xS in an ATM/CHK2-dependent manner, but how this shift is enforced is not known. Here, we show that in normally growing cells, when the 5' splice site of Bcl-xS is largely repressed, SRSF10 partially relieves repression and interacts with repressor hnRNP K and stimulatory hnRNP F/H proteins. Oxaliplatin abrogates the interaction of SRSF10 with hnRNP F/H and decreases the association of SRSF10 and hnRNP K with the Bcl-x pre-mRNA. Dephosphorylation of SRSF10 is linked with these changes. A broader analysis reveals that DNA damage co-opts SRSF10 to control splicing decisions in transcripts encoding components involved in DNA repair, cell-cycle control, and apoptosis. DNA damage therefore alters the interactions between splicing regulators to elicit a splicing response that determines cell fate.
RNA结合蛋白和信号转导成分控制着Bcl-x促死亡和促生存剪接变体的产生。奥沙利铂引发的DNA损伤以ATM/CHK2依赖的方式增加促凋亡Bcl-xS的水平,但这种转变是如何实现的尚不清楚。在此,我们表明,在正常生长的细胞中,当Bcl-xS的5'剪接位点受到很大程度的抑制时,SRSF10会部分解除这种抑制,并与阻遏物hnRNP K以及刺激性hnRNP F/H蛋白相互作用。奥沙利铂消除了SRSF10与hnRNP F/H的相互作用,并减少了SRSF10和hnRNP K与Bcl-x前体mRNA的结合。SRSF10的去磷酸化与这些变化有关。更广泛的分析表明,DNA损伤利用SRSF10来控制编码参与DNA修复、细胞周期调控和凋亡的成分的转录本中的剪接决定。因此,DNA损伤改变了剪接调节因子之间的相互作用,以引发决定细胞命运的剪接反应。